Back

Evaluation of effectiveness and outcomes of pulsed field ablation of atrial fibrillation in patients with obesity

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Catheter ablation procedural outcome Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Soroosh Aminolsharieh Najafi

CCB am Markus Hospital, Frankfurt am Main (Germany)

5 More presentations in this session

Presentation thumbnail
Pulsed filed ablation: comparison of procedural data and re-do data for the 31mm and 35mm device
Doctor L. Urbanek (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation, insights from the COMPARE CRYO study using continuous rhythm monitoring
Doctor S. Iqbal (Bern, CH)
Abstract Slides Video
Presentation thumbnail
1 year clinical & safety outcome of obese patients undergoing PVI for atrial fibrillation with pulsed field or cryoballoon ablation - a prospensity matched analysis
Doctor S. Feickert (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Three-year safety and effectiveness of Hybrid Ablation versus Catheter Ablation: Final results of the CEASE-AF trial
Professor P. Suwalski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Pulmonary vein reconnections at time of repeat procedure, variations by ablation modality.
Doctor K. Qazalbash (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation procedural outcome
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
1 year clinical & safety outcome of obese patients undergoing PVI for atrial fibrillation with pulsed field or cryoballoon ablation - a prospensity matched analysis
thumbnail
Congress Session
Atrial fibrillation: ablation 3
thumbnail
Congress Session
New modalities and strategies in catheter ablation of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources